Drug Screening System
Label-free SPR screening system for drug discovery.
Innovative screening technology for drug discovery detects small molecules that bind to target proteins. Advances in surface plasmon resonance (SPR) technology provide high throughput, sensitivity and outstanding cost efficiency.
Products
World's fastest label-free SPR detection system for fragment-based drug discovery (FBDD). This novel drug discovery strategy identifies small chemical fragments that bind weakly to biological targets. Fujifilm's high-sensitivity SPR biosensor can detect these small fragments with weak binding affinities more accurately, reliably and reproducibly than other SPR detection systems.
Note
- * Based on information on SPR label-free screening available to Fujifilm as of May 2007.
Speedy automated blood sample analysis in a convenient format.
- Products
- Consumer Products
- Business Products
- Support
- Digital Cameras and Printers
- Sustainability
- About Us
Fujifilm Corporation is a wholly-owned subsidiary of Fujifilm Holdings Corporation.